Gw&K Investment Management, LLC Albireo Pharma, Inc. Transaction History

Gw&K Investment Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.0 - $44.95 $0 - $28.5 Million	-633,621 Reduced 99.83%	1,080 $48,000
Q4 2022 Feb 10, 2023	SELL	$18.01 - $23.78 $163,728 - $216,183	-9,091 Reduced 1.41%	634,701 $13.7 Million
Q3 2022 Nov 09, 2022	BUY	$16.32 - $26.37 $5.14 Million - $8.31 Million	315,114 Added 95.87%	643,792 $12.5 Million
Q2 2022 Aug 09, 2022	BUY	$18.54 - $37.29 $231,657 - $465,938	12,495 Added 3.95%	328,678 $6.53 Million
Q1 2022 May 09, 2022	SELL	$23.94 - $33.74 $241,961 - $341,010	-10,107 Reduced 3.1%	316,183 $9.43 Million
Q4 2021 Feb 11, 2022	BUY	$21.19 - $31.29 $1.44 Million - $2.12 Million	67,909 Added 26.28%	326,290 $7.6 Million
Q3 2021 Nov 10, 2021	BUY	$27.36 - $35.98 $1.24 Million - $1.64 Million	45,477 Added 21.36%	258,381 $8.06 Million
Q2 2021 Aug 10, 2021	SELL	$28.9 - $36.87 $107,797 - $137,525	-3,730 Reduced 1.72%	212,904 $7.49 Million
Q1 2021 May 11, 2021	BUY	$32.03 - $42.85 $365,398 - $488,832	11,408 Added 5.56%	216,634 $7.64 Million
Q4 2020 Feb 05, 2021	BUY	$31.56 - $42.16 $1.67 Million - $2.22 Million	52,771 Added 34.61%	205,226 $7.7 Million
Q3 2020 Nov 10, 2020	BUY	$23.19 - $41.61 $3.54 Million - $6.34 Million	152,455 New	152,455 $5.09 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gw&K Investment Management, LLC with notifications on news.